This antibody recognizes recombinant thrombopoietin: 100%: 0%; TPO (14–29): ~80%; rEPO: 0%; ACTH (1–39): 0%; Calcitonin: 0%; Insulin: 0%; Insulin like Growth Factor 1: 0%; Insulin like Growth Factor 2: 0%; Parathyroid hormone: 0%. The clone number has been updated from (1.B.6) to (BDI321) both clone numbers name the same antibody clone.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ELISA (indirect): 1/30 - 1/100.
WB: Use at an assay dependent dilution. Predicted molecular weight: 38 kDa.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Lineage-specific cytokine affecting the proliferation and maturation of megakaryocytes from their committed progenitor cells. It acts at a late stage of megakaryocyte development. It may be the major physiological regulator of circulating platelets.
Defects in THPO are a cause of essential thrombocythemia (ET) [MIM:187950]. ET is inherited as an autosomal dominant trait which is characterized by elevated platelet levels due to sustained proliferation of megakaryocytes, and frequently lead to thrombotic and haemorrhagic complications.
Belongs to the EPO/TPO family.
Two-domain structure with an erythropoietin-like N-terminal and a Ser/Pro/Thr-rich C-terminal.